Table 2.
Rb1, P16 and ER protein expression in ovarian epithelial carcinoma cases studied according to clinico-pathologic variables (n = 130)
| IHC expression | Tumor size (pT) | Tumor grade | |||||
|---|---|---|---|---|---|---|---|
| T1 (n = 51) | T2 (n = 53) | T3 (n = 19) | G1 (n = 28) | G2 (n = 29) | G3 (n = 73) | G1/2 (n = 57) | |
| Rb1+ (n = 70) | 24 | 33 | 9 | 19 | 19 | 32 | 38 |
| P16+ (n = 71) | 27 | 27 | 13 | 7 | 11 | 53 | 18 |
| ER+ (n = 57) | 23 | 24 | 9 | 10 | 9 | 38 | 19 |
| Rb1+/P16+ (n = 30) | 9 | 11 | 8 | 3 | 5 | 19 | 8 |
| Rb1+/P16- (n = 40) | 18 | 24 | 1 | 10 | 16 | 14 | 26 |
| Rb1-/P16+ (n = 41) | 19 | 16 | 5 | 2 | 6 | 33 | 8 |
| Rb1+/ER- (n = 46) | 14 | 23 | 6 | 12 | 15 | 19 | 27 |
| Rb1+/ER+ (n = 24) | 10 | 10 | 3 | 7 | 4 | 13 | 11 |
| Rb1+/P16+/ER+ (n = 10) | 4 | 2 | 3 | 2 | 1 | 7 | 3 |
| Rb1-/P16-/ER- (n = 12) | 8 | 2 | 1 | 6 | 2 | 4 | 8 |